Biotech

All Articles

BMS centers bispecific months after filing to work stage 3 trial

.Bristol Myers Squibb has actually had a whiplash change of mind on its own BCMA bispecific T-cell e...

Charles Baum takes control of Terremoto as CEO

.Charles Baum, M.D., Ph.D., that supervised Mirati Therapies' $ 5.8 billion sale to Bristol Myers Sq...

Asarina to close after efforts to partner Tourette's drug neglect

.After connecting to greater than 200 companies to partner a Tourette syndrome therapy that presente...

Novartis pens $150M ahead of time bispecifics take care of Dren Biography

.Novartis has possessed some misfortune along with bispecific antibodies before, however evaluating ...

AstraZeneca vegetations an EGFR plant along with Pinetree deal worth $45M

.Pinetree Therapeutics will help AstraZeneca plant some trees in its pipe with a brand new treaty to...

GRO collects $60M series B to take gout treatment in to center

.GRO Biosciences has finished the week with an added $60.3 million in the bank, which the healthy pr...

Chutes &amp Ladders-- Gilead's Merdad Parsey goes, Cassava drops CEO

.Invite to today's Chutes &amp Ladders, our roundup of notable management hirings, firings as well a...